Femme et Homme
- | Pays :
- United States
- Canada
- | Organes : -
- | Spécialités : -
Extrait
This is a multi-center, open-label, Phase 2 study of carfilzomib to monitor the safety and efficacy of long-term or continuing carfilzomib therapy for subjects who previously completed a primary carfilzomib treatment study. Only subjects who have adequately completed a prior carfilzomib study will be eligible for the current study.
Critère d'inclusion
- Multiple myeloma